BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6365986)

  • 1. beta-2-microglobulin in benign and malignant adnexal skin tumors and metastasizing basocellular carcinomas.
    Kallioinen M; Dammert K
    J Cutan Pathol; 1984 Feb; 11(1):27-34. PubMed ID: 6365986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
    Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
    J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-2-Microglobulin in primordial and differentiated basocellular carcinomas and basosquamous carcinomas.
    Kallioinen M; Dammert K
    Acta Pathol Microbiol Immunol Scand A; 1983 Jul; 91(4):217-22. PubMed ID: 6191514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
    Hua LA; Kagen CN; Carpenter RJ; Goltz RW
    Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of HLA heavy chain and light chain (beta 2 microglobulin) expression on the cell surface of cutaneous malignancies.
    Mauduit G; Turbitt M; MacKie RM
    Br J Dermatol; 1983 Oct; 109(4):377-81. PubMed ID: 6414503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-2-microglobulin in basal cell carcinoma.
    Tjernlund UM; Forsum U
    Acta Derm Venereol; 1977; 57(6):503-6. PubMed ID: 73324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basement membrane laminin and type IV collagen in various benign and malignant adnexal tumors of the skin: an immunohistochemical study.
    Kallioinen M; Autio-Harmainen H; Dammert K; Risteli J; Risteli L
    J Invest Dermatol; 1984 Oct; 83(4):276-80. PubMed ID: 6090537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours.
    Petersen BL; Braendstrup O
    Int J Exp Pathol; 1993 Aug; 74(4):397-401. PubMed ID: 8398813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions.
    Turbitt ML; Mackie RM
    Br J Dermatol; 1981 May; 104(5):507-13. PubMed ID: 6165372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to intermediate filament proteins. The differential diagnosis of cutaneous tumors.
    Miettinen M; Lehto VP; Virtanen I
    Arch Dermatol; 1985 Jun; 121(6):736-41. PubMed ID: 2408582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basocellular carcinoma of the skin with metastases to lymph glands and the parotid].
    Bennedbaek O; Spaun E
    Ugeskr Laeger; 1990 Apr; 152(15):1096-8. PubMed ID: 2330634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-microglobulin as a marker of malignant epithelial tumors of the skin.
    Sarma DP; Olivier M; Goldsman C; Millikan LE
    J Surg Oncol; 1985 May; 29(1):61-5. PubMed ID: 3887039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrine differentiation in basocellular carcinoma].
    Collina G; Macrì L; Eusebi V
    Pathologica; 2001 Jun; 93(3):208-12. PubMed ID: 11433614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K; Hou-Jensen K; Werdelin O
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin molecules: a clue to the non-metastasizing behaviour of basal cell carcinomas?
    Baum HP; Schmid T; Reichrath J
    Acta Derm Venereol; 1996 Jan; 76(1):24-7. PubMed ID: 8721485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of beta2 microglobulin on the membrane of the keratinocyte in premalignant skin disorders.
    Vinninghe HR; Neumann HA
    Br J Dermatol; 1981 May; 104(5):515-9. PubMed ID: 6165373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and antigenic characteristics of basal cell carcinoma in culture.
    Bradbeer M; Bourne AJ; Ayberk H; Tang SK; Marks R
    Arch Dermatol Res; 1988; 280(4):228-34. PubMed ID: 2466442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
    González-Guerra E; Requena L; Kutzner H
    Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.